Patient's and Consultant's Views and Perceptions on Switching from an Originator Biologic to Biosimilar Medication: A Qualitative Study
The aim of this study was to describe the opinions of patients undergoing treatment with originator biologics and medical consultants managing their conditions and identify the barriers and enablers to transitioning from originator biologics to equivalent biosimilars. This study was undertaken prior...
Saved in:
Main Authors: | D. C. Rosembert (Author), M. J. Twigg (Author), D. J. Wright (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perception of Biosimilar Biologics and Non-Medical Prescription Switching among Rheumatologists: A Saudi Society for Rheumatology Initiative
by: Mohammed A. Omair, et al.
Published: (2022) -
The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
by: Claudia Fabiani, et al.
Published: (2019) -
Public deliberation to assess patient views on biosimilar medication switching for the treatment of inflammatory bowel disease
by: Kerry A. Ryan, et al.
Published: (2024) -
Implementing a Medication Switching Policy: Analysis of the Saskatchewan Biosimilars Initiative
by: Kirsten Fox
Published: (2024) -
Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking
by: Liese Barbier, et al.
Published: (2022)